Deciphering lipoprotein(a) atherogenicity with use of high-throughput proteomics

30 August 2024 (15:55 - 16:05)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jakub Morze

Chalmers University of Technology, Gothenburg (Sweden)

5 More presentations in this session

Presentation thumbnail

Comparative efficacy of colchicine and intensive LDL-C lowering in patients with ASCVD receiving statins: a network meta-analysis of randomised controlled trials

Doctor Z. Ou (Chongqing, CN)

Abstract Slides Video

Presentation thumbnail

The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.

Professor M. Banach (Lodz, PL)

Abstract Slides Video

Presentation thumbnail

Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study

Professor D. Nanchen (Lausanne, CH)

Abstract Slides Video

Presentation thumbnail

The change of paradigm: high HDL-c levels could not mean a long lifespan

Doctor F. Sousa (Funchal, PT)

Abstract Slides Video

Presentation thumbnail

Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study

Doctor S. Brennan (Dublin, IE)

Abstract Slides Video

Access the full session

Session thumbnail

Dyslipidaemia: novel diagnostics and therapy options

The Event

Event poster

ESC Congress 2024

30 August 2024 15:55 CET

You may be interested in

Congress Presentation

Plasma proteomic profiling reveals distinct lipoprotein roles in atherosclerosis

Congress Session

Controversies in lipoprotein(a)

Congress Presentation

Lp(a) epidemiology and pathophysiology

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources